These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31088312)

  • 1. Cannabinoid interactions with ion channels and receptors.
    Watkins AR
    Channels (Austin); 2019 Dec; 13(1):162-167. PubMed ID: 31088312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of cannabidiol on voltage-dependent sodium currents.
    Ghovanloo MR; Shuart NG; Mezeyova J; Dean RA; Ruben PC; Goodchild SJ
    J Biol Chem; 2018 Oct; 293(43):16546-16558. PubMed ID: 30219789
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabidiol interactions with voltage-gated sodium channels.
    Sait LG; Sula A; Ghovanloo MR; Hollingworth D; Ruben PC; Wallace BA
    Elife; 2020 Oct; 9():. PubMed ID: 33089780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity.
    Ghovanloo MR; Choudhury K; Bandaru TS; Fouda MA; Rayani K; Rusinova R; Phaterpekar T; Nelkenbrecher K; Watkins AR; Poburko D; Thewalt J; Andersen OS; Delemotte L; Goodchild SJ; Ruben PC
    J Gen Physiol; 2021 May; 153(5):. PubMed ID: 33836525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications.
    Ghovanloo MR; Ruben PC
    Neuroscientist; 2022 Aug; 28(4):318-334. PubMed ID: 34027742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Targets of Cannabidiol in Neurological Disorders.
    Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
    Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function.
    Milligan CJ; Anderson LL; Bowen MT; Banister SD; McGregor IS; Arnold JC; Petrou S
    J Cannabis Res; 2022 Jun; 4(1):30. PubMed ID: 35689251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol.
    Ghovanloo MR; Dib-Hajj SD; Goodchild SJ; Ruben PC; Waxman SG
    Front Physiol; 2022; 13():1066455. PubMed ID: 36439273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
    Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Regulation of Sodium Channels.
    D'Avanzo N
    Curr Top Membr; 2016; 78():353-407. PubMed ID: 27586290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
    Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
    Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of molecular targets and signaling pathways for CBD.
    de Almeida DL; Devi LA
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00682. PubMed ID: 33169541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
    Kozela E; Juknat A; Vogel Z
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.
    Luz-Veiga M; Azevedo-Silva J; Fernandes JC
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
    Straiker A; Dvorakova M; Zimmowitch A; Mackie K
    Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.